PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2017.3512018503823-834APEX1 Polymorphism and Mercaptopurine-Related Early Onset Neutropenia in Pediatric Acute Lymphoblastic LeukemiaHyery Kim, Heewon Seo, Yoomi Park, Byung-Joo Min, Myung-Eui Seo, Kyung Duk Park, Hee Young Shin, Ju Han Kim, Hyoung Jin Kanghttp://e-crt.org/upload/pdf/crt-2017-351.pdf, http://e-crt.org/journal/view.php?doi=10.4143/crt.2017.351, http://www.e-crt.org/upload/pdf/crt-2017-351.pdf
Children10.3390/children8030224202183224The Effect of NUDT15, TPMT, APEX1, and ITPA Genetic Variations on Mercaptopurine Treatment of Pediatric Acute Lymphoblastic LeukemiaJae Min Lee, Ye Jee Shim, Do-Hoon Kim, Nani Jung, Jung-Sook Hahttps://www.mdpi.com/2227-9067/8/3/224/pdf
Leukemia Research10.1016/j.leukres.2010.01.02920103481023-1026Thiopurine S-methyltransferase gene polymorphism and 6-mercaptopurine dose intensity in Indian children with acute lymphoblastic leukemiaGauri Kapoor, Rupal Sinha, Rahul Naithani, Meenal Chandgothiahttps://api.elsevier.com/content/article/PII:S0145212610000603?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0145212610000603?httpAccept=text/plain
Pediatric Acute Lymphoblastic Leukemia10.1007/978-981-15-0548-5_220199-19Genetic Alterations of Pediatric Acute Lymphoblastic LeukemiaToshihiko Imamurahttp://link.springer.com/content/pdf/10.1007/978-981-15-0548-5_2
Pediatric Acute Lymphoblastic Leukemia10.1007/978-981-15-0548-5_172019171-175Late Effects in Pediatric Acute Lymphoblastic LeukemiaMotohiro Katohttp://link.springer.com/content/pdf/10.1007/978-981-15-0548-5_17
Diagnostic Pathology: Pediatric Neoplasms10.1016/b978-0-323-54806-9.50180-42018776-777Early T-Cell Precursor Acute Lymphoblastic Leukemiahttps://api.elsevier.com/content/article/PII:B9780323548069501804?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:B9780323548069501804?httpAccept=text/plain
Journal of Pediatric Health Care10.1016/0891-5245(87)90143-x198715283Pharmacokinetic determinants of 6-mercaptopurine myelotoxicity and therapeutic failure in children with acute lymphoblastic leukemiahttps://api.elsevier.com/content/article/PII:089152458790143X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:089152458790143X?httpAccept=text/plain
Pharmaceuticals10.3390/ph150404162022154416Effect of ITPA Polymorphism on Adverse Drug Reactions of 6-Mercaptopurine in Pediatric Patients with Acute Lymphoblastic Leukemia: A Systematic Review and Meta-AnalysisYeonhong Lee, Eun Jeong Jang, Ha-Young Yoon, Jeong Yee, Hye-Sun Gwakhttps://www.mdpi.com/1424-8247/15/4/416/pdf
Pediatric Acute Lymphoblastic Leukemia10.1007/978-981-15-0548-5_112019101-108Acute Lymphoblastic Leukemia in Down SyndromeYasuhiro Okamotohttp://link.springer.com/content/pdf/10.1007/978-981-15-0548-5_11
Pediatric Acute Lymphoblastic Leukemia10.1007/978-981-15-0548-5_8201973-80Mature B-Cell Acute Lymphoblastic LeukemiaReiji Fukanohttp://link.springer.com/content/pdf/10.1007/978-981-15-0548-5_8